Barbara Fiacco

Barbara Fiacco is Co-Chair of the Patent Litigation Practice and represents life sciences companies and research institutions in complex intellectual property disputes. Her practice focuses on the biomedical field, including gene therapy, epigenetics, sequencing technology, recombinant DNA technology, therapeutic antibodies, small molecule compounds, drug delivery, molecular diagnostics, and medical devices.

She has represented leading pharmaceutical and life sciences clients in significant patent infringement lawsuits that have resulted in summary judgment or other favorable outcomes for her clients. Barbara also represents these clients in trade secret, inventorship, and collaboration disputes as well as other commercial litigation.

Barbara is a Past President of the American Intellectual Property Law Association (AIPLA) and a Past President of the United States section of the International Association for the Protection of Intellectual Property (AIPPI-US), serving from 2019 to 2020. She has held a number of leadership roles in AIPLA and has represented this premier intellectual property law association in testimony before the Senate Judiciary Committee’s Subcommittee on Intellectual Property as well as in amicus briefs to the Supreme Court.

Education: Harvard Law School, JD; Dartmouth College, AB